Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C21H31NO2 |
| Molecular Weight | 329.4763 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCCOC(=O)C1(C[C@@H]2CC[C@H]1C2)C3=CC=CC=C3
InChI
InChIKey=BDNMABJZSXTKAQ-VCPDFFEISA-N
InChI=1S/C21H31NO2/c1-3-22(4-2)13-8-14-24-20(23)21(18-9-6-5-7-10-18)16-17-11-12-19(21)15-17/h5-7,9-10,17,19H,3-4,8,11-16H2,1-2H3/t17-,19+,21?/m1/s1
| Molecular Formula | C21H31NO2 |
| Molecular Weight | 329.4763 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Bornaptine is a synthetic anticholinergic drug. The compound is a nonselective M1 and M4 antagonist and was shown to inhibit the negative inotropic response to carbachol in the isolated left atrium of the rat with pA2 of 7.27. Bornaprine is used for the treatment of symptoms of Parkinson's disease. A clinical trial showed the superiority of Bornaprine over placebo in reducing parkinsonian tremor. Bornaptine demonstrated positive results in localized hyperhidrosis.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:31:40 GMT 2025
by
admin
on
Mon Mar 31 18:31:40 GMT 2025
|
| Record UNII |
9M363FGA7J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
N04AA11
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
||
|
NCI_THESAURUS |
C29704
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
||
|
WHO-VATC |
QN04AA11
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
19610
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | RxNorm | ||
|
BORNAPRINE
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
70687267
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
9M363FGA7J
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
SUB05874MIG
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
DB13619
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
C90742
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
20448-86-6
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104596
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
100000088655
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
3897
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
C006088
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
390
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY | |||
|
DTXSID801043211
Created by
admin on Mon Mar 31 18:31:40 GMT 2025 , Edited by admin on Mon Mar 31 18:31:40 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |